Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Skin Toxicity × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1068 Carcinoma, Non-Small-Cell Lung 766 Prostatic Neoplasms 618 Neoplasms 517 Multiple Myeloma 458 Lymphoma 453 Colorectal Neoplasms 450 Lung Neoplasms 443 Leukemia 422 Neoplasm Metastasis 400 Leukemia, Myeloid, Acute 392 Melanoma 367 Lymphoma, Non-Hodgkin 343 Ovarian Neoplasms 342 Leukemia, Lymphocytic, Chronic, B-Cell 322 Pancreatic Neoplasms 318 Recurrence 289 Precursor Cell Lymphoblastic Leukemia-Lymphoma 267 Glioblastoma 256 Lymphoma, Large B-Cell, Diffuse 251 Head and Neck Neoplasms 250 Brain Neoplasms 247 Myelodysplastic Syndromes 244 Stomach Neoplasms 243 Lymphoma, Follicular 237 Carcinoma, Renal Cell 226 Rectal Neoplasms 220 Carcinoma, Hepatocellular 217 Hodgkin Disease 215 Sarcoma 209

Interventions

Tablets 1 Doxycycline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03448731 2020-04-08

DERMIA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 2 Completed

Skin Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡